Moolec Science Achieves First-Ever Bovine Myoglobin Expression in Pea Seeds, Validating Molecular Farming Platform
MLEC has more than doubled off its 52-week low of $3.077 on elevated volume (7.1× avg).
Summary
Moolec Science has announced a significant scientific breakthrough, successfully demonstrating the stable expression of bovine myoglobin in pea seeds. This marks the first reported instance of producing this heme-containing protein in peas, expanding the company's molecular farming platform beyond its current crop base. For a small, innovation-driven company like Moolec, this validation of their proprietary constructs in a new, globally relevant legume crop is highly material, reinforcing the scalability and versatility of their technology. This development strengthens Moolec's intellectual property and positions them for broader applications in the sustainable food industry, potentially unlocking new pathways for scalable protein production and long-term shareholder value. Investors will now watch for further progress in commercialization and product development leveraging this expanded platform.
At the time of this announcement, MLEC was trading at $10.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.3M. The 52-week trading range was $3.08 to $157.05. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Access Newswire.